Research Scientist at IM Therapeutics - Woburn, MA, US
CMC and Regulatory Sr. Manager
Contact Kaitlyn Sullivan
Manager Operations
Contact Monika Witczak
CEO, Board Member
Contact Nandan Padukone
VP, Immunology
Contact David Alleva
Vice President, Clinical Development
Contact Sarah Bird
Vice President, R&D
Contact Robert Perni
Clinical Trials Manager
Contact Janet Vogel
IM Therapeutics is building an HLA-directed platform for new therapies. We have demonstrated early effectiveness in type 1 diabetes and are building a pipeline of targeted therapies across autoimmune diseases.